In the RIVAWAR trial, patients hospitalized for a heart attack who were treated with rivaroxaban for left ventricular ...

At three months of follow-up, patients hospitalized for a serious heart attack who were treated with the oral blood thinner ...

Adapted with permission from [9,21]. Events Rivaroxaban (number per 100 patient years) Warfarin (number per 100 patient years) Rivaroxaban versus warfarin hazard ratio (95% CI) Primary safety ...

22,23 The ROCKET AF trial demonstrated that when rivaroxaban was used in AF patients at moderate to high risk for stroke, the drug was found to be noninferior to warfarin for the prevention of ...

[29] In the ROCKET AF trial (rivaroxaban versus warfarin for atrial fibrillation), the rate of major bleeding associated with an invasive procedure or surgery was 2.3 %. [30] Bleeding was similar ...